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Abstract.  The clathrin-coated pit lattice is held onto 
the plasma membrane by an integral membrane pro- 
tein that binds the clathrin AP-2 subunit with high 
affinity. In vitro studies have suggested that this pro- 
tein controls the assembly of the pit because mem- 
brane bound Apo2 is required for lattice assembly. If 
so, the AP-2 binding site must be a  resident protein of 
the coated pit and recycle with other receptors that en- 
ter cells through this pathway. Proper recycling, how- 
ever, would require the switching off of AP-2 binding 
to allow the binding site to travel through the endo- 
cytic pathway unencumbered.  Evidence for this hy- 
pothesis has been revealed by the cationic amphiphilic 
class of drugs (CAD),  which have previously been 
found to inhibit receptor recycling. Incubation of hu- 
man fibroblasts in the presence of these drugs caused 
clathrin lattices to assemble on endosomal membranes 
and at the same time prevented coated pit assembly at 
the cell surface. These effects suggest that CADs re- 
verse an on/off switch that controls AP-2 binding to 
membranes. We conclude that cells have a  mechanism 
for switching on and off AP-2 binding during the en- 
docytic cycle. 
ECEPTOR-MEDIATED-endocytosis  is a constitutive en- 
docytic process that uses clathrin-coated pits as the 
vehicle for internalization. The membrane coat is a 
polygonal lattice composed of clathrin triskelion and AP-2 
subunits (21).  AP-2 holds the clathrin lattice on the mem- 
brane by forming a  linkage between each triskelion and a 
high affinity binding site integral to the plasma membrane 
(24, 30). AP-2 may also modulate receptor clustering within 
the assembled pit (29). Receptors that are capable of cluster- 
ing contain a characteristic/S-turn motif in the cytoplasmic 
tail (4,  11). 
The steady state number of coated pits on the surface of 
each cell type is usually constant (2). The fusion of secretory 
vesicles during exocytosis, however,  can stimulate the for- 
mation of additional coated pits that retrieve excess mem- 
brane.  For example,  the  fertilization of a  sea urchin egg 
causes cortical granules to fuse with the plasma membrane, 
and this is immediately followed by a massive recruitment 
of clathrin-coated pits  to  the  membrane  (12).  Likewise, 
nerve terminal-derived-coated vesicles contain almost ex- 
clusively membrane that was inserted during synaptic vesicle 
exocytosis (25).  These observations raise questions about 
how the assembly of the pit is regulated and whether or not 
these regulatory mechanisms operate during each endocytic 
cycle. 
Receptor-mediated-endocytosis can  proceed  for  many 
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hours after ceils are incubated in the presence of protein syn- 
thesis inhibitors (2) because the component parts of each pit 
recycle. There are three populations of vesicles that recep- 
tors may encounter as they recycle (13, 28):  early endo- 
somes, late endosomes, and recycling vesicles. Clathrin and 
AP-2, by contrast, appear to dissociate from the membrane 
shortly after the formation of endosomes and remain soluble 
in the cytoplasm until used to assemble another coated pit 
(15, 31). 
The high affinity  AP-2 binding site responsible for holding 
the clathrin lattice on the membrane appears to be an integral 
membrane protein(s). Most likely it is internalized and recy- 
cled during endocytosis along with membrane proteins like 
the LDL receptor that reside in coated pits (8). This would 
require that AP-2 binding activity be turned off after inter- 
nalization to prevent subunit binding and subsequent assem- 
bly of coated pits on endosomal membranes. So far, the only 
marker  for the AP-2  binding  site is  the presence  of the 
clathrin lattice. 
Reagents that inhibit receptor recycling have been useful 
for identifying different stages in endocytosis (8). The most 
thoroughly studied group of inhibitors are those that elevate 
the pH of acidic compartments. They interfere with receptor 
recycling by inhibiting the dissociation of ligand from recep- 
tor, which leads to trapping of the receptor in endosomes 
(5).  A less well understood group of inhibitors are the cat- 
ionic amphiphilic drugs (9, 19). This class of drugs prevents 
recycling of receptors for transferrin (19), epidermal growth 
factor, and OtE-macroglobulin (9). The mechanism of inhibi- 
tion is not known but probably does not involve the disrup- 
tion of pH gradients in endosomes (9,  19). 
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Materials 
The following reagents were obtained from Sigma Chem. Co.  (St.  Louis, 
MO): bovine albumin fraction V (BSA, A-3294), bovine albumin fatty acid 
free  (A-6003),  Hepes  (H-3375),  chlorpromazine (C-8138)  sphingosine 
(S-6879),  imipramine  (I-7374),  calmidazolium  (C-3930),  chloroquine 
(C-6628),  PMA (P-8139), W-7 (A-3281), and staurosporine (S-4400). The 
following  reagents  were  from Calbioehem (La Jolla, CA):  caiphostin C 
(208725),  H-7  (371955),  K252a  (420300), monensin (475896),  and tri- 
fluoperazine  (642150).  The following reagents were purchased from Fluka 
Chemical Corp.  (Ronkonkoma,  NY):  trinitrophenol (80450)  and mag- 
nesium acetate (63047). Dextran sulfate was obtained from Pharmacia LKB 
Biotechnology (Pisea~,  NJ). Bicinchoninic acid was from Pierce (Rock- 
ford, IL).  1,4-diazabicyclo(2.2.2)-octane  was obtained from Aldrich (Mil- 
waukee, WI). Glutaraldehyde  (16320) and osmium tetroxide  (19176) were 
purchased from  Electron Microscopy  Sciences  (Fort Washington,  PA). 
Goat anti-mouse IgG conjugated  to FITC (62-6511) and goat anti-rabbit 
IgG conjugated  to FITC (62-6111) were obtained from Zymed Laborato- 
ries,  Inc.  (South San Francisco,  CA). Goat anti-rabbit IgG conjugated  to 
rhodamine was from Fisher Scientific  (Pittsburgh,  PA). Goat anti-mouse 
IgG conjugated  to 10-nm gold was obtained from Energy Beam Sciences 
(Agawam, MA). Mouse monoclonal antibodies that recognize the 100-kD 
c~ subunit of AP-2 (AP.6) and the clathrin heavy chain (X-22) were kindly 
provided by Dr. Francis Brodsky. Monoclonal IgG 2001 was used as a con- 
trol for all monoclonal antibodies (6). A rabbit polyclonal anti-LDL recep- 
tor IgG was prepared as previously  described (1). Human LDL was pre- 
pared and radiolabeled  with t25I as described (14). 
Buffers and Media 
Medium A was  Eagle's essential minimum medium without bicarbonate 
supplemented with 20 mM Hepes (pH 7.4) and 2 mg/ml BSA. Buffer B was 
150 mM NaCI, 50 mM Tris (pH 7.4) and 2 mg/ml BSA. Buffer C was buffer 
B without BSA. Buffer D was 50 mM NaC1, 10 mM Hepes (pH 7.4) and 
4 mg/ml dextran sulfate. Buffer E was 100 mM sodium phosphate (pH 7.4), 
150 mM NaCI.  Buffer F was 68.2 mM KCI, 4.1 mM Mg acetate and 36.4 
mM Hepes  (pH 7.2). Buffer G was  100 mM sodium phosphate (pH 7.4). 
Cell Culture 
Cultured fibroblasts were derived from a skin biopsy obtained from a nor- 
mal human subject.  Cells were grown in monolayer and set up for experi- 
ments according  to a standard format (14). On day 0, 7  x  104 cells were 
seeded  into each Pctri dish (100  x  15 ram) containing 10 ml DME sup- 
plemented with 100 U/ml penicillin, 100 #g/ml streptomycin,  and 10% 
(vol/vol) FCS.  Fresh medium of the same composition was added on day 
3.  On day  5  of cell growth,  each monolayer received  8  ml DME sup- 
plemented with penicillin, streptomycin,  5/zg/ml selenium, 5 #g/ml insu- 
lin, 5 #g/ml transferrin (ITS Premix), and 10% (vol/vol) human lipoprotein- 
deficient serum. Cells were used for all binding experiments  on day 7 of 
cell growth. 
Surface Binding of U~I-LDL 
LDL receptors were measured using a standard 125I-LDL binding assay 
performed in a 4°C cold room (14). Cells were incubated in the presence 
and absence of 50 #M chlorpromazine in medium A at 37°C for the indi- 
cated times and placed on ice for 30 min. Each monolayer  was quickly 
rinsed twice with 2 ml ice cold medium A. Each dish then received 2 mi 
ice cold medium A containing 10 #g/ml 125I-LDL in the presence or ab- 
sence of 500/zg/ml unlabeled LDL. After incubating at 4°C for 2 h, the 
medium was removed and each dish was rinsed three times with 3 ml ice 
cold buffer B. Each monolayer was then incubated twice for 10 min with 
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We  now  report  that  cationic  amphiphilic  drugs  cause 
coated pits to disappear  from the cell surface and reappear 
on endosomal membranes. The assembly of endosomal pits 
is inhibited at  18°C while at the same time disassembly of 
plasma membrane pits still takes place. These results suggest 
that  the  membrane  protein(s)  that  binds  AP-2  with  high 
affinity  is switched on and off during each endocytic cycle. 
Chlorpromazine  (pM) 
Figure  1.  Chlorpromazine  induces  the  disappearance  of  LDL 
receptors from the cell surface. Normal human fibroblasts were in- 
cubated in the presence of the indicated concentration of chlor- 
promazine (o) in medium A  for 30 min at 37°C. At the end of the 
incubations, cells were assayed for ~2~I-LDL binding as described 
in the methods. A separate set of cells (~, on the ordinate) was in- 
cubated in the presence of 25 #M monensin for 30 min at 37°C be- 
fore carrying out the  lUI-LDL binding assay.  All measurements 
are the average of duplicate values. Non-specific binding was <8 %. 
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Figure 2. Chlorpromazine reversibly traps LDL receptors inside of 
the cell. Normal human fibroblasts were incubated in the presence 
of 50 #M chlorpromazine in medium A for the indicated time. Af- 
ter 30  min of incubation the cells were  washed and  further in- 
cubated in medium A in the absence of the drug for various times. 
At the end of each time period,  the ceils were assayed for  1251- 
LDL binding as described.  All measurements are the average of 
duplicate values.  Non-specific binding was <5 %. 
The Journal of Cell Biology, Volume 123, 1993  1108 Figure 3. Effect of chlorpromazine on the distribution of LDL receptors in cultured fibroblasts. Normal human fibroblasts were incubated 
in the absence (A and C) and presence (B and D) of 100/zM chlorpromazine for 30 rain at 37°C. The cells were then either incubated 
in the presence of  anti-LDL receptor IgG at 4°C before fxation (A and B) or fixed, permeabilized and incubated with the anti-LDL receptor 
IgG.  Both sets of cells were processed to localize the bound IgG as described. Bar,  15/~m. 
3 ml ice cold buffer B, followed by one 10 min wash with 3 ml ice cold buffer 
C. After the extensive washing procedure, each dish received 2 ml of ice 
cold buffer D. The dishes were incubated at 4°C on a rotary shaker (40 rota- 
tions per rain) for 60 min. The buffer was removed and a l-rid aliquot was 
used to determine  the amount of  radioactivity released. The cells on the dish 
were then solubilized by incubating in 1 ml 0.1 N NaOH at room tempera- 
rare for 30 min.  An aliquot (50 ~1) was used for protein determination. 
Indirect Immunofluorescence Microscopy 
Indirect immunofluorescence was carried out by standard methods (1) using 
AP.6 and X-22 IgGs at a concentration of 5/~g/ml and purified rabbit anti- 
LDL receptor IgG at 10/zg/ml. All antibodies were diluted in buffer E con- 
taining 1% BSA and spun at 12,000 rpm for 10 min before use. For double 
staining, cells were incubated with both antibodies simultaneously. After 
each antibody incubation, cells were washed four times in buffer E contain- 
ing 0.1% BSA for 15 rain.  Each coverslip was rinsed with distilled water 
and  mounted  on  a  glass  slide  with  a  drop of 2.5%  1,4-diazabicyclo- 
(2.2.2)octane.  Cells were observed and photographed using a Zeiss pho- 
tomicroscope HI with appropriate filter packages. 
Immunogold Labeling 
Cells  were  incubated  in the presence  or absence  of chlorpromazine  in 
medium A for the indicated time and then chilled to 4°C. Cells were briefly 
washed twice with 3 ml ice cold buffer F followed by 5 min in 3 ml of ice 
cold buffer F containing 20/~g/ml digitonin. Cells were quickly rinsed twice 
with ice cold buffer F and fixed for 30 rain at 4°C in buffer G containing 
3%  paraformaldehyde,  3  mM KC1, 3 mM MgCI~, and  3 mM trinitro- 
phenol. After a 10-min incubation at room temperature in buffer G contain- 
ing 100 mM NH4CI, cells were incubated sequentially at room tempera- 
ture with 1% BSA in buffer G for 60 min,  10 t~g/ml of either AP.6 or 2001 
IgGs in buffer G for 3 h and a 1:50 dilution in buffer G of goat anti-mouse 
Wang et  al. Mis-Assembly of  Pits  1109 Figure 4.  Chlorpromazine causes the relocation of both clathrin (A and B) and AP-2 (C and D) from coated pits to vesicles in cultured 
fibroblasts. Normal human fibroblasts were incubated in the presence of 100 #M chlorpromazine for 30 min at 37°C. At the end of the 
incubation, cells were  fixed, permeabilized, and processed  to localize  either clathrin (A and B) or AP-2  (C and D) by indirect im- 
munofluorescence.  Bar,  15 #m. IgG conjugated  to 10 nrn gold  for 2 h. After  each  antibody  incubation, cells 
were washed for 15 rain at room  temperature with three changes of buffer 
G containing 0.1% BSA. Cells were then fixed with 2.5% ghtaraldehyde 
in buffer G at 4"C for 60 rain and washed three times with buffer G. The 
fixed ceils were posttixed at 40C for 60 min with 1% osmium tetroxide in 
buffer G containing 1.5 % potassium ferrocyanide  and washed five times 
with buffer G. Samples were embedded in Eponate and thin sectioned by 
standard methods. All pictures were taken with a JEOL 100 CX electron 
microscope. 
Other Methods 
Protein determinations were made using the Micro Bicinchoninic  Acid assay 
(35) using BSA as a standard. 
Results 
Chlorpromazine Inhibits LDL Receptor Recycling 
LDL receptors become trapped in endosomes when cells are 
incubated in the presence of monensin (5). To see if cationic 
amphiphilic drugs also affect LDL receptor recycling, we in- 
cubated cells at 37°C for 30 min in the presence of different 
concentrations of chlorpromazine, and then assayed for ~25I- 
LDL surface binding  at 4°C  (Fig.  1,  o).  We observed a 
progressive decline in the number of receptors on the cell 
surface  as  the  drug  concentration  was  increased.  Only 
,,ol 3 % of the receptors remained after incubation in 100/~M 
chlorpromazine. By contrast, 25 ttM monensin reduced sur- 
face receptors by <50% during the same incubation period 
(Fig.  1, •  on the ordinate). 
Almost immediately after we exposed the cells to 50/xM 
chlorpromazine, the receptors began to disappear from the 
surface (Fig.  2, o). Maximum loss occurred after 30 rain of 
incubation. Receptors rapidly reappeared on the cell surface 
when we removed the drug (wash, Fig. 2). Eighty-three per- 
cent of the original number of receptors were on the cell sur- 
face after a 30-min incubation at 37°C in the absence of the 
drug. 
We used indirect immunofluorescence to determine the 
fate of receptors during drug treatment (Fig.  3). Cells were 
incubated in the presence (Fig. 3, B and D) or absence (Fig. 
3, A and C) of the drug at 37°C for various times and assayed 
for the presence of  either surface (Fig. 3, A and B) or internal 
(Fig. 3, C and D) LDL receptors by indirect immunofluores- 
cence. Initially most of the receptors were on the cell sur- 
face, arranged in a typical punctate pattern (Fig. 3 A). Thirty 
minutes  of incubation  in  the presence of chlorpromazine 
caused receptors to leave the cell surface (compare Fig. 3 A 
with  3  B)  and  become  located  in  small  vesicles  in  the 
cytoplasm (compare Fig. 3 C with Fig. 3 D). We also noted 
that the amount of anti-receptor IgG binding to the Golgi 
area of the cell tended to increase (Fig. 3 D). After we re- 
moved the drug, most of the cells regained a normal surface 
staining pattern (data not shown). 
Figure 5. Time course for the chlorpromazine-induced redistribu- 
tion of AP-2 in fibroblasts. Normal human fibroblasts were in- 
cubated for 0 min (A), 10 min (B), or 30 min (C) in the presence 
of 100/tM chlorpromazine at 37°C. At the end of each incubation, 
the cells were fixed, permeabilized, and processed for indirect im- 
munofluorescence localization of AP-2. Bar, 15/zm. 
Wang et al. Mis-Assembly of Pits  1111 Chlorpromazine Causes Coated Pits to Assemble 
on Endosomes 
Monensin inhibits receptor recycling by trapping receptors 
in  endosomes  but  it  does  not  affect  the  distribution  of 
clathrin-coated pits  (5).  This was  not the case for cldor- 
promazine. When we treated cells with this drug for 30 min 
at 37°C, fixed, and then stained with anti-clathrin IgG (Fig. 
4), the clathrin was no longer present on the cell surface in 
coated pits (compare Fig. 4 A with B). Instead, staining was 
associated  with  numerous vesicles  deep  within  the cyto- 
plasm of  the cell. Often the staining was organized into quad- 
rants at the periphery of  each vesicle, suggesting that clathrin 
was only partially coating the membrane.  The exact same 
staining pattern was seen when we replaced the anti-clathrin 
IgG with an IgG specific for AP-2 (compare Fig. 4  C with 
4D). 
Immunofluorescence shows that anti-AP-2 IgG stains al- 
most exclusively coated pits in human fibroblasts (Fig. 4 C), 
which indicates that this subunit is not normally present on 
early endosomes and must dissociate soon after coated vesi- 
cles form. To determine if chlorpromazine prevented the un- 
coating of the clathrin coat after vesicle formation, we used 
immunofluorescence to follow the distribution of AP-2 in 
cells that were incubated in the presence of chlorpromazine 
for various times at 37°C (Fig. 5). The earliest change ob- 
served (5-10 min of incubation) was the disappearance of 
AP-2 from the cell surface (compare Fig. 5 A with 5 B) and 
a  concomitant  increase  in  diffuse  as  well  as  particulate 
fluorescence in the cytoplasm of the cell. This was followed 
by the appearance of  distinct vesicle staining after 15-30 min 
of incubation (Fig. 5  C). 
These  results  suggested  that  chlorpromazine  was  not 
preventing  the  uncoating  of  coated  vesicles.  This  was 
confirmed when we incubated cells in the presence of the 
drug at 180C for 30 min (Fig. 6) and found that rather than 
being bound to a membrane, AP-2 was diffusely distributed 
in the cytoplasm of the cell (Fig. 6, compare B with A). If 
we maintained a set of these cells in the drug while shifting 
the temperature to 37°C, the diffuse AP-2 staining promptly 
changed to the vesicle staining pattern (Fig. 6, compare C 
with B). The same result was obtained with anti-clathrin IgG 
(data not shown). Therefore, the loss of clathrin/AP-2 from 
the plasma membrane and appearance on vesicles appear to 
be separate events. 
The  effect  of  chlorprornazine  on  the  distribution  of 
clathrin/AP-2 was reversible (Fig. 7). Cells incubated in the 
presence of chlorpromazine for 30 min at 370C displayed 
AP-2 on vesicles instead of coated pits (Fig. 7, compare A 
with B). When we washed away the drug, a normal coated 
pit staining pattern was observed after just 30 rain of incuba- 
tion (Fig. 7, compare B with C). 
Figure 6.  The effects of chlorpromazine on AP-2 distribution at 
18°C (B) vs 37°C (C).  Either ceils were not treated (A) or were 
incubated in the presence of 100 #M chlorpromazine for 30 min 
at 18°C (B and C). One set of these cells was maintained at 18°C 
(B) while the other (C) was shifted to 37°C before both were in- 
cubated in the presence of chlorpromazine an additional 30 min. 
The cells were all fixed, permeabilized, and processed for indirect 
immunofluorescence localization of AP-2. Bar, 15 ~,m. 
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Coated pit  Vesicle 
Drug tested  Amount  staining  staining 
25  ~M  +  Monensin 
Sphingosine 
Trifluoperazine 
Imiprarnine 
Chlorpromazine 
W-7 
PMA 
Chlorpromazine/PMA 
Calphostin C 
H-7 
Staurosporine 
K252a 
Calmidazolium 
Cbloroquine 
20  LM 
25  ~M 
200  ~M 
50  tM 
100  ~M 
1  zM 
50/1  LM 
1  ~M 
50  ~M 
1  zM 
1  tM 
2  ~M 
200  ~M 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Normal human  fibroblasts were incubated in the presence  of  the indicated  drug 
for 30 min at 37"C. At the end of the incubation, the ceils were processed for 
immunofluorescence  as described. Each sample was scored for either coated 
pit staining (Fig. 4 A) or vesicle staining (Fig. 4 B) as shown in Fig. 4. 
To better define the mechanism of action of chlorproma- 
zine, we assayed a number of other drugs for their effects on 
clathrin/AP-2  distribution  (Table  I).  All of the phenothia- 
zincs, as well as sphingosine, caused clathrin/AP-2 redistri- 
bution. Compounds that elevate the pH of intracellular com- 
partments (e.g., monensin) had no effect. Drugs that tend to 
inhibit calmodulin-dependent  functions  (e.g.,  W-7) caused 
mis-assembly while those that specifically inhibit protein ki- 
nase C (e.g., Calphostin C) did not affect AP-2 distribution. 
One exception was calmidazolium, which had no effect even 
though it  specifically  inhibits  calmodulin  dependent  func- 
tions (7,  16). 
The vesicle population decorated with clathrin/AP-2 was 
identified by electron microscopy (Fig. 8). We first incubated 
fibroblasts in the presence of  chlorpromazine for 30 min, and 
then disrupted the cells and applied anti-AP-2 IgG followed 
by immunogold. Like normal cells, chlorpromazine treated 
cells had numerous multivesicular bodies (late endosomes). 
A  portion of the outer membrane of many of these vesicles 
was decorated with a  fuzzy coat that had the characteristic 
appearance  of a  clathrin  lattice  (arrows, Fig.  8, A-C, E). 
Some vesicles had more than one coated region (arrow, Fig. 
8 E). Usually the coat was much larger than the typical size 
of a surface coated pit (Fig. 8, A-C, E). Each coat was also 
positively stained with anti-AP-2 IgG specific immunogold 
(arrows, Fig, 8, A, (7, and E) but not nonimmune IgG (Fig. 
8 B). We did not see any other membrane compartments that 
were labeled with either anti-AP-2 IgG gold or fuzzy coats. 
In addition, fuzzy coats were never seen on endosomal struc- 
tures of untreated cells  (Fig.  8 D). 
Figure 7. Chlorprornazine induced relocation of AP-2 is reversible. 
Normal human fibroblasts  were either  not incubated  (A) or in- 
cubated in the presence of 100/~M  chlorpromazine for 30 rain at 
37"C (B and C). One set of  the chiorpromazine incubated cells (C) 
was further incubated for 30 rain at 37"C in the absence of  the drug. 
All cells were fixed and processed for indirect immunofluorescence 
as described.  Bar,  15/zm. 
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with Different Vesicles 
Chlorpromazine could inhibit LDL receptor recycling be- 
cause the receptor becomes entangled in endosomal coated 
pits.  Therefore,  we used indirect immunofluorescence to 
colocalize receptors and AP-2 at various times after treat- 
ment with chlorpromazine (Fig. 9). The two markers were 
initially together in coated pits at the cell surface (Fig. 9, A 
and B). Cells incubated for 10 min in the presence of chlor- 
promazine had LDL receptors in small vesicles that were de- 
void of anti-AP-2 IgG staining (Fig. 9, compare C with D). 
After 30 rain of incubation, prominent endosomal staining 
of AP-2  was observed,  but none of these structures were 
positive for anti-LDL receptor staining (Fig. 9, compare E 
with F). Therefore, AP-2 binding sites and LDL receptors 
are trapped in different compartments in response to chlor- 
promazine. 
Discussion 
Chlorpromazine causes the loss of coated pits from the sur- 
face of the cell and the appearance of clathrin coats com- 
posed  of the  same  subunits  on  endosomal  membranes. 
Chlorpromazine  has  revealed  a  previously  unrecognized 
regulatory step in receptor-mediated-endocytosis: the mem- 
brane  binding  of AP-2  and the  subsequent  formation of 
clathrin lattices. A likely site of regulation is the binding of 
AP-2  to its high affinity binding site.  These results are in 
agreement with the recent studies of Seaman et al. (33) who 
found that AP-2 binding to membranes and coated pit assem- 
bly can be modulated in broken cell preparations by either 
calcium or GTP'rS. 
AP-2 Receptor 
Virshup and Bennett (36) were the first to show that mem- 
branes from both coated vesicles and whole brains could 
bind isolated APs. AP-binding activity was further defined 
by Mahaffey et ai.  (24)  who discovered a membrane pro- 
tein(s) within coated pits that binds AP-2 with high affinity. 
The AP-2 subunit consists of two distinct domains, referred 
to as the core and the appendage (18, 22), that can be sepa- 
rated after proteolysis. Only the core domain binds to the 
AP-2 binding site (30).  In addition, this is the domain that 
binds clathrin during lattice assembly (30).  Treatment of 
membranes with proteases removes the binding site (30), 
which prevents AP-2 binding and lattice assembly. 
These data suggest that active AP-2 binding sites are the 
controlling element for clathrin lattice assembly. These sites 
appear to be integral membrane proteins and most likely 
recycle because other plasma membrane proteins that enter 
cells through coated pits recycle (8). To avoid making coated 
pits in recycling compartments, the AP-2 binding site must 
be  switched off shortly after coated vesicle formation. It 
must then be switched back on upon returning to the cell sur- 
face. Chlorpromazine appears to be affecting the switching 
mechanism. 
Cells incubated in the presence of chlorpromazine at 18°C 
lost  surface  clathrin/AP-2  but  after  the  temperature  was 
shifted to 37°C the subunits appeared on endosomes. Other 
workers have shown that endosomal fusion is retarded at 
18°C  while ligand internalization, receptor recycling, and 
coated vesicle uncoating are unaffected (10, 17). Perhaps the 
initial loss of clathrin/AP-2 in the above experiment is a con- 
sequence of the normal uncoating process while the chlor- 
promazine inactivated all of the AP-2 binding sites.  When 
the temperature was shifted to 37°C in the presence of the 
drug, only the endosomal binding sites were activated. This 
is consistent with in vitro experiments showing that either 
Ca++ or  GTP~S  can  switch  lattice  assembly  from  the 
plasma membrane to endosomes (33). 
The LDL receptor and clathrin/AP-2 did not colocalize af- 
ter ceils were incubated in the presence of chlorpromazine. 
Therefore, the AP-2 binding site and the LDL receptor be- 
come trapped in different vesicle populations of the endo- 
cytic pathway. This implies that the cytoplasmic tail of  recep- 
tors like the LDL receptor are not the high affinity AP-2 
binding site. On the other hand, transfected cells that over 
express transferrin receptors  appear to have an increased 
number of clathrin lattices (20,  26),  which suggests that 
receptor tails can influence pit assembly. 
We conclude that chlorpromazine activates a population of 
recycling AP-2 binding sites that normally are inactive. The 
natural  cationic  amphiphilic  molecule  sphingosine  also 
causes anomalous binding of clathrin/AP-2 on endosomes 
when added exogenously to  cells  (Table  I).  Endogenous 
sphingosine-l-phosphate appears to regulate cell motility, tu- 
mor cell invasiveness,  and cell proliferation (23, 32). Recent 
experiments with clathrin deficient Dictyostelium have sug- 
gested that clathrin-coated pits  are  important for proper 
chemotactic motility (27). These observations raise the pos- 
sibility that endogenous CADs might control the direction of 
cell movement by regulating coated pit assembly. 
Mechanism of  Action of CAD 
CADs affect the activity of many different enzymes. For ex- 
ample,  they  inhibit  phosphatidic  acid  phosphohydrolase, 
CTP:phosphocholine cytidyltransferase, protein kinase C, 
Ca++/calmodulin-dependent enzymes, Na+,K+-ATPase, but 
activate phospholipase  D  (23).  Protein kinase C  (3)  and 
calmodulin (16) have both been  found to  affect receptor 
traffic during receptor-mediated-endocytosis. 
PMA,  an activator of protein kinase C,  stimulates the 
hyperpbosphorylation and the internalization of transferrin 
receptors (for review see 34). Trifluoperazine, a CAD that 
causes clathrirdAP-2 assembly on endosomes (Table I), has 
the same effect as PMA (19). In contrast to these results, we 
found that PMA had no effect on clathrin/AP-2 distribution 
(Table I). Even pretreatment of cells with PMA before chlor- 
promazine did not prevent the relocation of clathrin/AP-2 to 
endosomes. Calphostin C, a potent inhibitor of protein ki- 
nase C, also did not affect clathrin distribution (Table  D- 
These results suggest that protein kinase C is not involved 
in regulating pit assembly. 
Inhibitors of calmodulin function also impair transferrin 
receptor recycling (16). We had less success obtaining direct 
information on the role of calmodulin in clathrin/AP-2 relo- 
cation. Two specific inhihitors of Ca++/calmodulin-depen - 
dent enzymes that were tested are W-7 and calmidazolium. 
The former caused clathrin/AP-2 relocation to endosomes 
while the latter had no effect (Table I). The recent finding by 
Seaman  et  al.  (33)  that  high  Ca  ++  can  cause  the  mis- 
assembly of coated pits on endosomal membranes in vitro 
The Journal of Cell Biology, Volume 123,  1993  1114 Figure 8. Chlorpromazine causes clathrin and AP-2 to relocate to 
multivesicular  bodies. Normal human fibroblasts were incubated in 
the presence (A-C, E) or the absence (D) of chlorpromazine for 
30 rain at 37°C. At the end of the incubation, cells were processed 
for immunogold localization of either anti-AP-2 IgG binding sites 
(A, C, and E) or nonimmune  IgG binding sites (B and D) as de- 
scribed.  Untreated  cells were processed  for electron microscopy 
only. Bar, 0.21 /~m. 
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AP-2 binding. 
Control of  Endocytosis 
Chlorpromazine has revealed a regulatory site for control- 
ling coated pit assembly. The effects of the drug indicate that 
normally the activation of pit assembly at the cell surface is 
somehow synchronized with the inactivation of pit assembly 
on newly formed endosomes. This suggests the existence of 
a  molecular switch, possibly one that is controlled by cal- 
cium or GTP (33), that turns on and off AP-2 binding to its 
binding  site.  This  switch  may  play  an  important  role  in 
regulating coated pit formation in instances where massive 
recruitment of membrane to the cell surface occurs during 
exocytosis. 
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Figure 9. Colocalization of AP-2 (A, C, and E) and LDL receptor (B, D, and F) before (A and B) and after (C-F)  treatment with chlorproma- 
zine. Normal human fibroblasts were either not incubated (A and B) or were incubated in the presence of 50/~M chlorpromazine  for 10 
min (C and D) or 30 min (E and F). At the end of the incubations, the cells were fixed and processed for immunofluorescence as described. 
Bar,  15 #m. 
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